These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

343 related articles for article (PubMed ID: 33645231)

  • 1. Development of a Prodrug of Camptothecin for Enhanced Treatment of Glioblastoma Multiforme.
    Checa-Chavarria E; Rivero-Buceta E; Sanchez Martos MA; Martinez Navarrete G; Soto-Sánchez C; Botella P; Fernández E
    Mol Pharm; 2021 Apr; 18(4):1558-1572. PubMed ID: 33645231
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined treatment with niclosamide and camptothecin enhances anticancer effect in U87 MG human glioblastoma cells.
    Valdez L; Cheng B; Gonzalez D; Rodriguez R; Campano P; Tsin A; Fang X
    Oncotarget; 2022; 13():642-658. PubMed ID: 35548329
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Self-assembling and self-formulating prodrug hydrogelator extends survival in a glioblastoma resection and recurrence model.
    Schiapparelli P; Zhang P; Lara-Velazquez M; Guerrero-Cazares H; Lin R; Su H; Chakroun RW; Tusa M; Quiñones-Hinojosa A; Cui H
    J Control Release; 2020 Mar; 319():311-321. PubMed ID: 31911154
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reactive oxygen species responsive nanoprodrug to treat intracranial glioblastoma.
    Lee BS; Amano T; Wang HQ; Pantoja JL; Yoon CW; Hanson CJ; Amatya R; Yen A; Black KL; Yu JS
    ACS Nano; 2013 Apr; 7(4):3061-77. PubMed ID: 23557138
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antitumor compound testing in glioblastoma organotypic brain cultures.
    Biggs T; Foreman J; Sundstrom L; Regenass U; Lehembre F
    J Biomol Screen; 2011 Sep; 16(8):805-17. PubMed ID: 21807962
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel anti-glioblastoma agents and therapeutic combinations identified from a collection of FDA approved drugs.
    Jiang P; Mukthavaram R; Chao Y; Bharati IS; Fogal V; Pastorino S; Cong X; Nomura N; Gallagher M; Abbasi T; Vali S; Pingle SC; Makale M; Kesari S
    J Transl Med; 2014 Jan; 12():13. PubMed ID: 24433351
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Redox-responsive amphiphilic camptothecin prodrug nanoparticles for targeted liver tumor therapy.
    Lu L; Li B; Lin C; Li K; Liu G; Xia Z; Luo Z; Cai K
    J Mater Chem B; 2020 May; 8(17):3918-3928. PubMed ID: 32227058
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gene expression time-series analysis of camptothecin effects in U87-MG and DBTRG-05 glioblastoma cell lines.
    Morandi E; Severini C; Quercioli D; D'Ario G; Perdichizzi S; Capri M; Farruggia G; Mascolo MG; Horn W; Vaccari M; Serra R; Colacci A; Silingardi P
    Mol Cancer; 2008 Aug; 7():66. PubMed ID: 18694480
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Resveratrol targeting of AKT and p53 in glioblastoma and glioblastoma stem-like cells to suppress growth and infiltration.
    Clark PA; Bhattacharya S; Elmayan A; Darjatmoko SR; Thuro BA; Yan MB; van Ginkel PR; Polans AS; Kuo JS
    J Neurosurg; 2017 May; 126(5):1448-1460. PubMed ID: 27419830
    [TBL] [Abstract][Full Text] [Related]  

  • 10. OTX015 (MK-8628), a novel BET inhibitor, displays in vitro and in vivo antitumor effects alone and in combination with conventional therapies in glioblastoma models.
    Berenguer-Daizé C; Astorgues-Xerri L; Odore E; Cayol M; Cvitkovic E; Noel K; Bekradda M; MacKenzie S; Rezai K; Lokiec F; Riveiro ME; Ouafik L
    Int J Cancer; 2016 Nov; 139(9):2047-55. PubMed ID: 27388964
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preclinical effects of CRLX101, an investigational camptothecin-containing nanoparticle drug conjugate, on treating glioblastoma multiforme via apoptosis and antiangiogenesis.
    Lin CJ; Lin YL; Luh F; Yen Y; Chen RM
    Oncotarget; 2016 Jul; 7(27):42408-42421. PubMed ID: 27285755
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antitumor potential of a novel camptothecin derivative, ZBH-ZM-06.
    Wu D; Zhao DW; Li YQ; Shi WG; Yin QL; Tu ZK; Yu YY; Zhong BH; Yu H; Bao WG
    Oncol Rep; 2018 Feb; 39(2):871-879. PubMed ID: 29251321
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Albumin-binding prodrugs of camptothecin and doxorubicin with an Ala-Leu-Ala-Leu-linker that are cleaved by cathepsin B: synthesis and antitumor efficacy.
    Schmid B; Chung DE; Warnecke A; Fichtner I; Kratz F
    Bioconjug Chem; 2007; 18(3):702-16. PubMed ID: 17378599
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tannic acid elicits selective antitumoral activity in vitro and inhibits cancer cell growth in a preclinical model of glioblastoma multiforme.
    Bona NP; Pedra NS; Azambuja JH; Soares MSP; Spohr L; Gelsleichter NE; de M Meine B; Sekine FG; Mendonça LT; de Oliveira FH; Braganhol E; Spanevello RM; da Silveira EF; Stefanello FM
    Metab Brain Dis; 2020 Feb; 35(2):283-293. PubMed ID: 31773434
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Temporary blood-brain barrier disruption by low intensity pulsed ultrasound increases carboplatin delivery and efficacy in preclinical models of glioblastoma.
    Dréan A; Lemaire N; Bouchoux G; Goldwirt L; Canney M; Goli L; Bouzidi A; Schmitt C; Guehennec J; Verreault M; Sanson M; Delattre JY; Mokhtari K; Sottilini F; Carpentier A; Idbaih A
    J Neurooncol; 2019 Aug; 144(1):33-41. PubMed ID: 31197598
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antitumor Effects of 5-Aminolevulinic Acid on Human Malignant Glioblastoma Cells.
    Jalili-Nik M; Abbasinezhad-Moud F; Sahab-Negah S; Maghrouni A; Etezad Razavi M; Khaleghi Ghadiri M; Stummer W; Gorji A
    Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34070493
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of cytotoxic properties of a cyclopamine glucuronide prodrug in rat glioblastoma cells and tumors.
    Bensalma S; Chadeneau C; Legigan T; Renoux B; Gaillard A; de Boisvilliers M; Pinet-Charvet C; Papot S; Muller JM
    J Mol Neurosci; 2015 Jan; 55(1):51-61. PubMed ID: 25280457
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improved tumor targeting and antitumor activity of camptothecin loaded solid lipid nanoparticles by preinjection of blank solid lipid nanoparticles.
    Jang DJ; Moon C; Oh E
    Biomed Pharmacother; 2016 May; 80():162-172. PubMed ID: 27133053
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antitumor effect of DX-8951, a novel camptothecin analog, on human pancreatic tumor cells and their CPT-11-resistant variants cultured in vitro and xenografted into nude mice.
    Takiguchi S; Kumazawa E; Shimazoe T; Tohgo A; Kono A
    Jpn J Cancer Res; 1997 Aug; 88(8):760-9. PubMed ID: 9330608
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peptide grafted and self-assembled poly(γ-glutamic acid)-phenylalanine nanoparticles targeting camptothecin to glioma.
    Kulhari H; Telukutla SR; Pooja D; Shukla R; Sistla R; Bansal V; Adams DJ
    Nanomedicine (Lond); 2017 Jul; 12(14):1661-1674. PubMed ID: 28635550
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.